Clin2
NCT07336966Possibly a fitNot yet recruiting

Do WFS1 gene changes cause a certain type of vision loss?

Wolfram Syndrome 1Optic Atrophies, Hereditary

Part of Brain & nervous system, Ear, nose & throat, Eyes & vision, Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study looks at people with a change in the WFS1 gene to see if it can cause a specific form of inherited vision loss. If you have this gene change, joining may help doctors better understand your condition.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
45 people
Ages
Any age
Study type
Observational

Who can take part

  • You have had a genetic test showing a change in the WFS1 gene.
  • You are willing to have your medical records or genetic results reviewed.
  • You do not have a change in the WFS2 gene.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02841553Recruiting
Online registry for Wolfram syndrome worldwide

This study builds an international online registry to learn how Wolfram syndrome (and related WFS1 conditions) changes over time. It may help researchers understand the disease course and improve future care by collecting health and family history data.

St Louis, Missouri
NCT07729982Recruiting
Study tracking vision changes in OPA1 optic atrophy

This study follows people with a genetic form of optic atrophy over time to understand how vision changes. It does not test a treatment but helps doctors learn more about the condition to improve care.

Munich, Bavaria
NCT06345898Recruiting· Early Phase 1
Gene therapy for X-linked retinoschisis in young males

This trial tests a single gene therapy injection under the retina for boys with X-linked retinoschisis, a condition that causes vision loss. It aims to see if the treatment is safe and can improve vision.

Chengdu, Sichuan
NCT07303296Recruiting· Phase 2
Gene therapy study for vision loss from LHON

This trial tests a gene therapy called GS010 given as an injection into the eye for people with vision loss from LHON. It aims to see if it can help improve vision in both eyes.

Paris
NCT05757141Recruiting· Phase 1/Phase 2
Study of fosigotifator for vanishing white matter disease

This study tests a new medicine called fosigotifator for people with vanishing white matter disease (VWM), a rare genetic condition that affects the brain and movement. It aims to see if the medicine is safe and helpful for patients from infancy to adulthood.

Boston, Massachusetts
NCT06545253Not yet recruiting
New imaging method for vision loss from USH2A gene changes

This study tests a new imaging technique to better understand and monitor a type of inherited vision loss caused by changes in the USH2A gene. It may help improve diagnosis and future treatment planning for people with this condition.

Hear when a new Wolfram Syndrome 1 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.